Versant Capital Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84K | Sell |
224
-1,812
| -89% | -$14.9K | ﹤0.01% | 2401 |
|
|
2025
Q1 | $14.6K | Buy |
2,036
+635
| +45% | +$4.54K | ﹤0.01% | 1516 |
|
|
2024
Q4 | $10.8K | Buy |
1,401
+291
| +26% | +$2.25K | ﹤0.01% | 1353 |
|
|
2024
Q3 | $11.6K | Buy |
1,110
+1,081
| +3,728% | +$11.3K | ﹤0.01% | 1006 |
|
|
2024
Q2 | $339 | Hold |
29
| – | – | ﹤0.01% | 1842 |
|
|
2024
Q1 | $611 | Hold |
29
| – | – | ﹤0.01% | 1650 |
|
|
2023
Q4 | $521 | Hold |
29
| – | – | ﹤0.01% | 1666 |
|
|
2023
Q3 | $477 | Sell |
29
-26
| -47% | -$428 | ﹤0.01% | 1702 |
|
|
2023
Q2 | $1.1K | Buy |
55
+26
| +90% | +$520 | ﹤0.01% | 1569 |
|
|
2023
Q1 | $524 | Hold |
29
| – | – | ﹤0.01% | 1578 |
|
|
2022
Q4 | $658 | Sell |
29
-213
| -88% | -$4.83K | ﹤0.01% | 1394 |
|
|
2022
Q3 | $6K | Buy |
+242
| New | +$6K | ﹤0.01% | 798 |
|
|
2022
Q2 | – | Sell |
-65
| Closed | -$2K | – | 1618 |
|
|
2022
Q1 | $2K | Buy |
+65
| New | +$2K | ﹤0.01% | 1175 |
|
|
2019
Q2 | – | Sell |
-27
| Closed | -$1K | – | 1640 |
|
|
2019
Q1 | $1K | Sell |
27
-10
| -27% | -$370 | ﹤0.01% | 1480 |
|
|
2018
Q4 | $1K | Buy |
37
+6
| +19% | +$162 | ﹤0.01% | 1391 |
|
|
2018
Q3 | $2K | Buy |
31
+22
| +244% | +$1.42K | ﹤0.01% | 1319 |
|
|
2018
Q2 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1620 |
|